GlassScriptPhysician profile
Caroline M Schmidt
NPI 1760773790
$5,301.52
in general payments reported to CMS, 2019-2025
18 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,855 · 2020: $1,141 · 2021: $1,618 · 2022: $91.42 · 2023: $310 · 2024: $94.81 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $2,670.68 | 2019-2023 | |
| Allergan, INC. | $955.75 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $825.00 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $193.84 | 2024-2025 | Xdemvy |
| Abbvie INC. | $126.69 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $91.57 | 2020-2021 | |
| Alcon Vision LLC | $74.83 | 2019-2023 | Rocklatan |
| Bausch & Lomb Americas INC. | $72.29 | 2022-2024 | Envista Mx60 Iol, Vyzulta |
| Novartis Pharmaceuticals Corporation | $52.24 | 2019 | |
| Iridex Corporation | $50.52 | 2020 | |
| Aerie Pharmaceuticals, INC. | $43.54 | 2020-2021 | |
| Glaukos Corporation | $31.66 | 2023 | |
| Genentech USA, INC. | $25.54 | 2024 | Vabysmo |
| Kala Pharmaceuticals, INC. | $22.48 | 2022 | |
| Akorn, INC. | $19.85 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $19.25 | 2022 | |
| Biotissue Holdings INC. | $16.52 | 2019 | |
| Quidel Corporation | $9.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.